AbbVie Inc (ABBV)

Current ratio

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Total current assets	US$ in thousands	25,582,000	27,785,000	33,816,000	38,871,000	33,002,000	33,224,000	28,852,000	26,488,000	28,463,000	30,364,000	29,100,000	26,509,000	27,928,000	28,957,000	25,999,000	26,569,000	24,173,000	23,009,000	21,256,000	51,758,000
Total current liabilities	US$ in thousands	38,749,000	43,062,000	41,915,000	41,522,000	37,841,000	34,773,000	32,239,000	27,590,000	29,538,000	32,712,000	34,473,000	32,521,000	35,194,000	28,533,000	28,684,000	31,951,000	28,661,000	24,181,000	24,646,000	16,471,000
Current ratio		0.66	0.65	0.81	0.94	0.87	0.96	0.89	0.96	0.96	0.93	0.84	0.82	0.79	1.01	0.91	0.83	0.84	0.95	0.86	3.14

December 31, 2024 calculation

Current ratio = Total current assets ÷ Total current liabilities
= $25,582,000K ÷ $38,749,000K
= 0.66

The current ratio for AbbVie Inc has fluctuated over the past few years, ranging from a high of 3.14 on March 31, 2020 to a low of 0.65 on September 30, 2024. Generally, a current ratio above 1 indicates that a company has more current assets than current liabilities, suggesting strong liquidity and the ability to cover short-term obligations.

AbbVie's current ratio was consistently above 1 from March 31, 2020 to September 30, 2021, indicating a healthy financial position. However, the ratio dipped below 1 from December 31, 2021 to December 31, 2024, which may raise concerns about the company's ability to meet its short-term obligations.

It is essential for AbbVie Inc to closely monitor its current ratio and take necessary steps to ensure it remains at a healthy level to maintain financial stability and meet its liquidity needs.